Teva Pharmaceutical Industries Statistics Share Statistics Teva Pharmaceutical Industries has 1.15B
shares outstanding. The number of shares has increased by 1.22%
in one year.
Shares Outstanding 1.15B Shares Change (YoY) 1.22% Shares Change (QoQ) 0.09% Owned by Institutions (%) 62.03% Shares Floating 1.15B Failed to Deliver (FTD) Shares 534,000 FTD / Avg. Volume 4.62%
Short Selling Information The latest short interest is 53.42M, so 4.66% of the outstanding
shares have been sold short.
Short Interest 53.42M Short % of Shares Out 4.66% Short % of Float 4.68% Short Ratio (days to cover) 5.38
Valuation Ratios The PE ratio is -15.21 and the forward
PE ratio is 5.95.
Teva Pharmaceutical Industries's PEG ratio is
-0.08.
PE Ratio -15.21 Forward PE 5.95 PS Ratio 1.51 Forward PS 1.1 PB Ratio 4.63 P/FCF Ratio 33.28 PEG Ratio -0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Teva Pharmaceutical Industries.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.98,
with a Debt / Equity ratio of 3.36.
Current Ratio 0.98 Quick Ratio 0.75 Debt / Equity 3.36 Debt / EBITDA 23.27 Debt / FCF 24.14 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $447.14K Profits Per Employee $-44.3K Employee Count 37,000 Asset Turnover 0.42 Inventory Turnover 2.82
Taxes Income Tax 676M Effective Tax Rate -52.65%
Stock Price Statistics The stock price has increased by -3.86% in the
last 52 weeks. The beta is 0.62, so Teva Pharmaceutical Industries's
price volatility has been higher than the market average.
Beta 0.62 52-Week Price Change -3.86% 50-Day Moving Average 16.72 200-Day Moving Average 17.24 Relative Strength Index (RSI) 50.99 Average Volume (20 Days) 11,551,333
Income Statement In the last 12 months, Teva Pharmaceutical Industries had revenue of 16.54B
and earned -1.64B
in profits. Earnings per share was -1.45.
Revenue 16.54B Gross Profit 8.06B Operating Income -303M Net Income -1.64B EBITDA 777M EBIT -282M Earnings Per Share (EPS) -1.45
Full Income Statement Balance Sheet The company has 3.3B in cash and 18.08B in
debt, giving a net cash position of -14.78B.
Cash & Cash Equivalents 3.3B Total Debt 18.08B Net Cash -14.78B Retained Earnings -15.17B Total Assets 40.13B Working Capital 759M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 1.25B
and capital expenditures -498M, giving a free cash flow of 749M.
Operating Cash Flow 1.25B Capital Expenditures -498M Free Cash Flow 749M FCF Per Share 0.66
Full Cash Flow Statement Margins Gross margin is 48.74%, with operating and profit margins of -1.83% and -9.91%.
Gross Margin 48.74% Operating Margin -1.83% Pretax Margin -7.76% Profit Margin -9.91% EBITDA Margin 4.7% EBIT Margin -1.83% FCF Margin 4.53%
Dividends & Yields TEVA pays an annual dividend of $1.19,
which amounts to a dividend yield of 5.8%.
Dividend Per Share $1.19 Dividend Yield 5.8% Dividend Growth (YoY) 0% Payout Ratio -793.33% Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TEVA is $23.5,
which is 43.1% higher than the current price. The consensus rating is "Buy".
Price Target $23.5 Price Target Difference 43.1% Analyst Consensus Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 1, 2004. It was a
forward
split with a ratio of 2:1.
Last Split Date Jul 1, 2004 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 1.04 Piotroski F-Score 5
